Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
51.9M
-
Shares change
-
+2.57M
-
Total reported value, excl. options
-
$754M
-
Value change
-
+$37.2M
-
Number of buys
-
55
-
Number of sells
-
-21
-
Price
-
$14.53
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q2 2022
109 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q2 2022.
Avidity Biosciences, Inc. - Common Stock (RNA) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.9M shares
of 120M outstanding shares and own 43.22% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7.88M shares), RTW INVESTMENTS, LP (4.8M shares), BlackRock Inc. (3.93M shares), FMR LLC (3.81M shares), EcoR1 Capital, LLC (2.76M shares), FEDERATED HERMES, INC. (2.47M shares), VANGUARD GROUP INC (2.42M shares), COWEN AND COMPANY, LLC (2.26M shares), RA CAPITAL MANAGEMENT, L.P. (2.17M shares), and Avidity Partners Management LP (2.08M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.